Skip to main content

E907 5 Pill - pink eight-sided, 8mm

Generic Name: oxymorphone

Pill with imprint E907 5 is Pink, Eight-sided and has been identified as Opana ER 5 mg. It is supplied by Endo Pharmaceuticals Inc.

Opana ER is used in the treatment of Pain and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Opana ER 5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for E907 5

Opana ER 5 mg E907     5

Opana ER

Generic Name
oxymorphone
Imprint
E907 5
Strength
5 mg
Color
Pink
Size
8.00 mm
Shape
Eight-sided
Availability
Prescription only
Drug Class
Opioids (narcotic analgesics)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Endo Pharmaceuticals Inc.
National Drug Code (NDC)
63481-0907 (Discontinued)
Inactive Ingredients
hypromelloses, methylparaben, sodium stearyl fumarate, titanium dioxide, triacetin, polyethylene glycol, polysorbate 80, ferric oxide red

Note: Inactive ingredients may vary.

Submitted by: Drugs.com

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.